Surfactant status in preterm neonates recovering from respiratory distress syndrome

Pediatrics

Volumn 122, Issue 1, 2008, Pages 102-108

  Verlato, Giovanna ^a   Cogo, Paola Elisa ^a   Balzani, Marco ^a   Gucciardi, Antonina ^a   Burattini, Ilaria ^b   De Benedictis, Fernando ^b   Martiri, Giovanna ^b   Carnielli, Virgilio Paolo ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Isotopes; Low birth weight infants; Pulmonary surfactant; Respiratory distress syndrome

Indexed keywords

CARBON 13; DIPALMITOYLPHOSPHATIDYLCHOLINE; OXYGEN; PORACTANT; WATER; LUNG SURFACTANT; PHOSPHATIDYLCHOLINE;

ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; DRUG HALF LIFE; ENDOTRACHEAL INTUBATION; EXTUBATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY FAILURE; RESPIRATORY TRACT PARAMETERS; RETREATMENT; TREATMENT FAILURE; CLINICAL TRIAL; HALF LIFE TIME; LOW BIRTH WEIGHT; METABOLISM; MULTICENTER STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME;

CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HALF-LIFE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PHOSPHATIDYLCHOLINES; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 48249117950     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-1021     Document Type: Article

References (41)

1. Martin RJ, Walsh-Sukys MC. Bronchopulmonary dysplasia: no simple solution. N Engl J Med. 1999;340(13):1036-1038
2. Avery ME, Tooley WH, Keller JB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics. 1987;79(1):26-30
3. Stefanescu BM, Murphy WP, Hansell BJ, Fuloria M, Morgan TM, Aschner JL. A randomized, controlled trial comparing two different continuous positive airway pressure systems for the successful extubation of extremely low birth weight infants. Pediatrics. 2003;112(5):1031-1038
4. Kavvadia V, Greenough A, Dimitriou G. Prediction of extubation failure in preterm neonates. Eur J Pediatr. 2000;159(4):227-231
5. Davis PG, Henderson-Smart DJ. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev. 2000; (3):CD000143
6. Vento G, Tortorolo L, Zecca E, et al. Spontaneous minute ventilation is a predictor of extubation failure in extremely-low-birth-weight infants. J Matern Fetal Neonatal Med. 2004;15(3):147-154
7. Kamlin CO, Davis PG, Morley CJ. Predicting successful extubation of very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2006;91(3):F180-F183
8. Halliday HL. Towards earlier neonatal extubation. Lancet. 2000; 355(9221):2091-2092
9. Halliday HL. What interventions facilitate weaning from the ventilator? A review of the evidence from systematic reviews. Paediatr Respir Rev. 2004;5(suppl A):S347-S352
10. Bunt JE, Zimmermann LJ, Wattimena JL, van Beek RH, Sauer PJ, Carnielli VP. Endogenous surfactant turnover in preterm infants measured with stable isotopes. Am J Respir Crit Care Med. 1998;157(3):810-814
11. Cavicchioli P, Zimmermann LJ, Cogo PE, et al. Endogenous surfactant turnover in preterm infants with respiratory distress syndrome studied with stable isotope lipids. Am J Respir Crit Care Med. 2001;163(1):55-60
12. Bunt JE, Carnielli VP, Seidner SR, et al. Metabolism of endogenous surfactant in premature baboons and effect of prenatal corticosteroids. Am J Respir Crit Care Med. 1999;160(5):1481-1485
13. Torresin M, Zimmermann LJ, Cogo PE, et al. Exogenous surfactant kinetics in infant respiratory distress syndrome: a novel method with stable isotopes. Am J Respir Crit Care Med. 2000;161(5):1584-1589
14. Verlato G, Cogo PE, Gucciardi A, et al. Surfactant disaturated phosphatidylcholine (DSPC) kinetics in neonatal pneumonia and in newborn infants with respiratory distress syndrome (RDS). Pediatr Res. 2004;55(4):513A
15. Merrill JD, Ballard RA, Cnaan A, et al. Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res. 2004;56(6):918-926
16. Hallman M, Haataja R. Surfactant protein polymorphisms and neonatal lung disease. Semin Perinatol. 2006;30(6):350-361
17. Hallman M, Haataja R. Genetic basis of respiratory distress syndrome. Front Biosci. 2007;12(1):2670-2682
18. Pavlovic J, Papagaroufalis C, Xanthou M, et al. Genetic variants of surfactant proteins A, B, C, and D in bronchopulmonary dysplasia. Dis Markers. 2006;22(5-6):277-291
19. Maritz GS, Cock ML, Louey S, Suzuki K, Harding R. Fetal growth restriction has long-term effects on postnatal lung structure in sheep. Pediatr Res. 2004;55(2):287-295
20. Janssen DJ, Carnielli VP, Cogo PE, et al. Surfactant phosphati- dylcholine half-life and pool size measurements in premature baboons developing bronchopulmonary dysplasia. Pediatr Res. 2002;52(5):724-729
21. Cogo PE, Zimmermann LJ, Meneghini L, et al. Pulmonary surfactant disaturated-phosphatidylcholine (DSPC) turnover and pool size in newborn infants with congenital diaphragmatic hernia (CDH). Pediatr Res. 2003;54(5):653-658
22. Cogo PE, Zimmermann LJ, Pesavento R, et al. Surfactant kinetics in preterm infants on mechanical ventilation who did and did not develop bronchopulmonary dysplasia. Crit Care Med. 2003;31(5):1532-1538
23. Mulrooney N, Champion C, Moss TJM, Nitsos I, Ikegami M, Jobe A. Surfactant and physiologic responses of preterm lambs to continuous positive airway pressure. Am J Respir Crit Care Med. 2005;171(5):488-493
24. Seidner SR, Jobe A, Coalson JJ, Ikegami M. Abnormal surfactant metabolism and function in preterm ventilated baboons. Am J Respir Crit Care Med. 1998;158(6):1982-1989
25. Rebello CM, Jobe AH, Eisele JW, Ikegami M. Alveolar and tissue surfactant pool sizes in humans. Am J Respir Crit Care Med. 1996;154(3):625-628
26. American College of Obstetricians and Gynecologists. ACOG committee opinion: inappropriate use of terms fetal distress and birth asphyxia: number 197. Int J Gynaecol Obstet. 1998; 61(3):309-310
27. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37(8):911-917
28. Cogo PE, Carnielli VP, Bunt JE, et al. Endogenous surfactant metabolism in critically ill infants measured with stable isotope labeled fatty acids. Pediatr Res. 1999;45(2):242-246
29. Gillespie LM, White SD, Sinha SK, Donn SM. Usefulness of the minute ventilation test in predicting successful extubation in newborn infants: a randomized controlled trial. J Perinatol. 2003;23(3):205-207
30. Hallman M, Merritt TA, Pohjavuori M, Gluck L. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr Res. 1986;20(12):1228-1235
31. Griese M, Dietrich P, Reinhardt D. Pharmacokinetics of bovine surfactant in neonatal respiratory distress syndrome. Am J Respir Crit Care Med. 1995;152(3):1050-1054
32. Tormena F, Zimmermann LJ, Cogo PE, et al. Effect of 100 vs 200 mg/kg of exogenous surfactant on pulmonary surfactant kinetics in preterm infants with RDS. Pediatr Res. 2001;49S(4):382A
33. Kallapur SG, Jobe AH. Contribution of inflammation to lung injury and development. Arch Dis Child Fetal Neonatal Ed. 2006; 91(2):F132-F135
34. Ballard PL, Merrill JD, Godinez RI, Godinez MH, Truog WE, Ballard RA. Surfactant protein profile of pulmonary surfactant in premature infants. Am J Respir Crit Care Med. 2003;168(9): 1123-1128
35. Cogo PE, Zimmermann LJ, Verlato G, et al. A dual stable isotope tracer method for the measurement of surfactant disaturated-phosphatidylcholine net synthesis in infants with congenital diaphragmatic hernia. Pediatr Res. 2004;56(2):184-190
36. Bohlin K, Merchak A, Spence K, Patterson BW, Hamvas A. Endogenous surfactant metabolism in newborn infants with and without respiratory failure. Pediatr Res. 2003;54(2):185-191
37. Bohlin K, Patterson BW, Spence KL, et al. Metabolic kinetics of pulmonary surfactant in newborn infants using endogenous stable isotope techniques. J Lipid Res. 2005;46(6):1257-1265
38. Spence KL, Zozobrado JC, Patterson BW, Hamvas A. Substrate utilization and kinetics of surfactant metabolism in evolving bronchopulmonary dysplasia. J Pediatr. 2005;147(4):480-485
39. Janssen DJ, Carnielli VP, Cogo PE, et al. Surfactant phosphati- dylcholine metabolism in neonates with meconium aspiration syndrome. J Pediatr. 2006;149(5):634-639
40. Pandit PB, Dunn MS, Kelly EN, Perlman M. Surfactant replacement in neonates with early chronic lung disease. Pediatrics. 1995;95(6):851-854
41. Merrill JD, Ballard PL, Hibbs AM, et al. Booster surfactant therapy beyond the first week of life in ventilated extremely low gestational age infants. E-PAS2006:59:2635. 1. Available at: www. abstracts2view. com/pasall/index. php. Accessed May 14, 2008